LOC646719 Activators is a term that refers to a specific category of chemical compounds designed to selectively increase the activity of the protein encoded by the gene locus LOC646719. This class encompasses a variety of molecules that may differ in structure but are unified by their functional objective: to bind to and enhance the activity of this particular protein. The development of such activators is a sophisticated endeavor rooted in molecular biology and chemistry. It requires a comprehensive understanding of the protein's structure, the regulatory mechanisms governing its activity, and the intricate network of interactions in which it participates within the cellular milieu. Researchers harness techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy to obtain high-resolution images of the protein. These images are pivotal for revealing potential binding sites that are amenable to the attachment and action of activator molecules.
Once potential binding sites on the protein are identified, the search for effective activators involves sifting through vast chemical libraries to pinpoint molecules that demonstrate an affinity for the protein. High-throughput screening methods facilitate this process, enabling the rapid assessment of thousands of compounds for their ability to bind to the protein. The selected compounds are then subject to further analysis to determine their efficacy in enhancing the protein's activity. Structure-activity relationship (SAR) studies play a crucial role in this phase, as they help to refine the chemical structure of the activators for optimal interaction with the protein. Lead compounds that emerge from these studies are characterized by their ability to bind at the identified sites and modulate the protein's function in a predictable and controlled manner. These activators are usually bespoke molecules tailored through iterative cycles of synthesis and testing to achieve the desired level of potency and selectivity for the target protein. The ultimate goal of developing LOC646719 activators is to harness biochemical principles to modulate a specific protein function within its native cellular context.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a DNA methyltransferase inhibitor, azacitidine can induce hypomethylation of gene promoters, potentially increasing non-coding RNA transcription. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to azacitidine, decitabine may also cause DNA demethylation, which could activate the transcription of non-coding RNAs. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
This HDAC inhibitor may enhance transcription by increasing chromatin accessibility, potentially affecting non-coding RNA expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
As an HDAC inhibitor, panobinostat can modify chromatin structure, possibly leading to the induction of non-coding RNA expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Another HDAC inhibitor that can alter the chromatin landscape, potentially affecting the transcription of non-coding RNAs like the NIPBL divergent transcript. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a non-nucleoside DNA methyltransferase inhibitor that might upregulate non-coding RNA transcription by reducing DNA methylation. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can inhibit DNA methyltransferase, which might increase the expression of certain non-coding RNAs through epigenetic changes. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
As a tyrosine kinase inhibitor, genistein may have epigenetic effects that could potentially upregulate non-coding RNA expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin is known to have a broad range of biological effects, including the potential to modify gene expression, possibly affecting non-coding RNAs. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol impacts gene expression through various signaling pathways, which could theoretically include non-coding RNA expression. | ||||||